US Stock MarketDetailed Quotes

SGMT Sagimet Biosciences

Watchlist
  • 2.520
  • -0.150-5.62%
Close Sep 6 16:00 ET
  • 2.650
  • +0.130+5.16%
Post 17:16 ET
81.13MMarket Cap-2748P/E (TTM)

Sagimet Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
1.50%-5.63M
12.37%-6.21M
2.96%-23.77M
4.96%-7.08M
37.78%-3.88M
6.81%-5.72M
-51.85%-7.08M
-12.81%-24.49M
-7.45M
-6.23M
Net income from continuing operations
-19.65%-8.12M
-0.64%-6.63M
8.60%-27.88M
-13.29%-8.15M
14.92%-6.35M
4.46%-6.79M
24.59%-6.59M
-24.78%-30.5M
---7.2M
---7.47M
Operating gains losses
----
----
-33.33%-4K
----
----
----
200.00%2K
-50.00%-3K
----
----
Other non cash items
2.94%35K
5.88%36K
6.92%139K
9.09%36K
6.06%35K
6.25%34K
6.25%34K
-2.99%130K
--33K
--33K
Change In working capital
7,485.00%1.48M
85.69%-181K
-123.21%-978K
69.86%-280K
-34.78%587K
-103.39%-20K
-134.63%-1.27M
7,761.82%4.21M
---929K
--900K
-Change in prepaid assets
-0.97%408K
1,829.73%640K
-166.30%-952K
-610.91%-562K
-532.23%-765K
520.41%412K
-102.39%-37K
404.88%1.44M
--110K
---121K
-Change in payables and accrued expense
375.51%1.09M
34.45%-782K
-95.88%120K
131.84%320K
31.66%1.39M
-155.85%-396K
-155.33%-1.19M
420.54%2.92M
---1.01M
--1.06M
-Change in other current liabilities
38.89%-22K
-11.43%-39K
-6.57%-146K
-11.76%-38K
-8.82%-37K
-71.43%-36K
27.08%-35K
4.86%-137K
---34K
---34K
Cash from discontinued investing activities
Operating cash flow
1.50%-5.63M
12.37%-6.21M
2.96%-23.77M
4.96%-7.08M
37.78%-3.88M
6.81%-5.72M
-51.85%-7.08M
-12.81%-24.49M
---7.45M
---6.23M
Investing cash flow
Cash flow from continuing investing activities
-687.16%-75.16M
-84.54%3M
139.30%12.58M
-460.93%-19.62M
0
130.88%12.8M
19.4M
-32.01M
5.44M
4M
Net investment purchase and sale
-687.16%-75.16M
-84.54%3M
139.30%12.58M
-460.93%-19.62M
--0
130.88%12.8M
--19.4M
---32.01M
--5.44M
--4M
Cash from discontinued investing activities
Investing cash flow
-687.16%-75.16M
-84.54%3M
139.30%12.58M
-460.93%-19.62M
--0
130.88%12.8M
--19.4M
---32.01M
--5.44M
--4M
Financing cash flow
Cash flow from continuing financing activities
97.03%-27K
77,192.65%104.85M
118,136.99%86.17M
0
87.21M
-2,933.33%-910K
-1,233.33%-136K
-100.75%-73K
-55K
0
Net common stock issuance
--0
--105.75M
--89.68M
--3.52M
--86.16M
--0
--0
--0
--0
----
Proceeds from stock option exercised by employees
--0
--114K
-50.00%6K
--0
--6K
--0
--0
-93.65%12K
--0
--0
Net other financing activities
97.03%-27K
-648.53%-1.02M
-4,038.82%-3.52M
----
----
---910K
---136K
93.22%-85K
---55K
--0
Cash from discontinued financing activities
Financing cash flow
97.03%-27K
77,192.65%104.85M
118,136.99%86.17M
--0
--87.21M
-2,933.33%-910K
-1,233.33%-136K
-100.75%-73K
---55K
--0
Net cash flow
Beginning cash position
1,332.78%176.78M
47,456.33%75.14M
-99.72%158K
4,466.91%101.84M
314.61%18.51M
-76.31%12.34M
-99.72%158K
-17.42%56.73M
--2.23M
--4.46M
Current changes in cash
-1,409.85%-80.82M
734.47%101.64M
232.54%74.98M
-1,188.75%-26.7M
3,830.26%83.33M
112.96%6.17M
361.77%12.18M
-372.58%-56.57M
---2.07M
---2.23M
End cash Position
418.47%95.96M
1,332.78%176.78M
47,456.33%75.14M
47,456.33%75.14M
4,466.91%101.84M
314.61%18.51M
-76.31%12.34M
-99.72%158K
--158K
--2.23M
Free cash flow
1.50%-5.63M
12.37%-6.21M
2.96%-23.77M
4.96%-7.08M
37.78%-3.88M
6.81%-5.72M
-51.85%-7.08M
-12.81%-24.49M
---7.45M
---6.23M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 1.50%-5.63M12.37%-6.21M2.96%-23.77M4.96%-7.08M37.78%-3.88M6.81%-5.72M-51.85%-7.08M-12.81%-24.49M-7.45M-6.23M
Net income from continuing operations -19.65%-8.12M-0.64%-6.63M8.60%-27.88M-13.29%-8.15M14.92%-6.35M4.46%-6.79M24.59%-6.59M-24.78%-30.5M---7.2M---7.47M
Operating gains losses ---------33.33%-4K------------200.00%2K-50.00%-3K--------
Other non cash items 2.94%35K5.88%36K6.92%139K9.09%36K6.06%35K6.25%34K6.25%34K-2.99%130K--33K--33K
Change In working capital 7,485.00%1.48M85.69%-181K-123.21%-978K69.86%-280K-34.78%587K-103.39%-20K-134.63%-1.27M7,761.82%4.21M---929K--900K
-Change in prepaid assets -0.97%408K1,829.73%640K-166.30%-952K-610.91%-562K-532.23%-765K520.41%412K-102.39%-37K404.88%1.44M--110K---121K
-Change in payables and accrued expense 375.51%1.09M34.45%-782K-95.88%120K131.84%320K31.66%1.39M-155.85%-396K-155.33%-1.19M420.54%2.92M---1.01M--1.06M
-Change in other current liabilities 38.89%-22K-11.43%-39K-6.57%-146K-11.76%-38K-8.82%-37K-71.43%-36K27.08%-35K4.86%-137K---34K---34K
Cash from discontinued investing activities
Operating cash flow 1.50%-5.63M12.37%-6.21M2.96%-23.77M4.96%-7.08M37.78%-3.88M6.81%-5.72M-51.85%-7.08M-12.81%-24.49M---7.45M---6.23M
Investing cash flow
Cash flow from continuing investing activities -687.16%-75.16M-84.54%3M139.30%12.58M-460.93%-19.62M0130.88%12.8M19.4M-32.01M5.44M4M
Net investment purchase and sale -687.16%-75.16M-84.54%3M139.30%12.58M-460.93%-19.62M--0130.88%12.8M--19.4M---32.01M--5.44M--4M
Cash from discontinued investing activities
Investing cash flow -687.16%-75.16M-84.54%3M139.30%12.58M-460.93%-19.62M--0130.88%12.8M--19.4M---32.01M--5.44M--4M
Financing cash flow
Cash flow from continuing financing activities 97.03%-27K77,192.65%104.85M118,136.99%86.17M087.21M-2,933.33%-910K-1,233.33%-136K-100.75%-73K-55K0
Net common stock issuance --0--105.75M--89.68M--3.52M--86.16M--0--0--0--0----
Proceeds from stock option exercised by employees --0--114K-50.00%6K--0--6K--0--0-93.65%12K--0--0
Net other financing activities 97.03%-27K-648.53%-1.02M-4,038.82%-3.52M-----------910K---136K93.22%-85K---55K--0
Cash from discontinued financing activities
Financing cash flow 97.03%-27K77,192.65%104.85M118,136.99%86.17M--0--87.21M-2,933.33%-910K-1,233.33%-136K-100.75%-73K---55K--0
Net cash flow
Beginning cash position 1,332.78%176.78M47,456.33%75.14M-99.72%158K4,466.91%101.84M314.61%18.51M-76.31%12.34M-99.72%158K-17.42%56.73M--2.23M--4.46M
Current changes in cash -1,409.85%-80.82M734.47%101.64M232.54%74.98M-1,188.75%-26.7M3,830.26%83.33M112.96%6.17M361.77%12.18M-372.58%-56.57M---2.07M---2.23M
End cash Position 418.47%95.96M1,332.78%176.78M47,456.33%75.14M47,456.33%75.14M4,466.91%101.84M314.61%18.51M-76.31%12.34M-99.72%158K--158K--2.23M
Free cash flow 1.50%-5.63M12.37%-6.21M2.96%-23.77M4.96%-7.08M37.78%-3.88M6.81%-5.72M-51.85%-7.08M-12.81%-24.49M---7.45M---6.23M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg